Cargando…
High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?
BACKGROUD: COVID-19 coagulopathy linked to increased D-dimer levels has been associated with high mortality (Fei Z et al. in Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229):1054–62, 20...
Autores principales: | Ibañez, C., Perdomo, J., Calvo, A., Ferrando, C., Reverter, J. C., Tassies, D., Blasi, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363162/ https://www.ncbi.nlm.nih.gov/pubmed/32671609 http://dx.doi.org/10.1007/s11239-020-02226-0 |
Ejemplares similares
-
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
por: Blasi, Annabel, et al.
Publicado: (2020) -
“Going with the flow” in modeling fibrinolysis
por: Whyte, Claire S., et al.
Publicado: (2022) -
Fibrinolysis and D-dimer in COVID-19: A Twisted Plot!
por: Magoon, Rohan, et al.
Publicado: (2022) -
Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study
por: Calvo, Andrea, et al.
Publicado: (2022) -
D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients
por: Trimaille, Antonin, et al.
Publicado: (2020)